7:30 CEST our Q2 2022 financial results will be released. The
company announcement will be available here
Get all the details and materials you need to attend our conference calls or just listen in via live webcasts.
7:30 CEST our Q3 2022 financial results will be released. The
company announcement will be available here
Get all the details and materials you need to attend our conference calls or just listen in via live webcasts.
Watch the presentations and get the slides from the Novo Nordisk Capital Markets Day.
5 June: Investor event (ADA 82nd Scientific Sessions)
Presentation (Webcast)
Presentation (pdf)
Conference call webcast (05 May 2021, 13:00 CET)
Conference call audio link (05 May 2021, 13:00 CET)
London webcast (06 May 2021, 13:00 CET)
London earnings presentation audio link (06 May 2021, 13:00 CET)
20 December: Conference call on supply situation for Wegovy®
Presentation (Webcast)
Presentation (pdf)
28 June: R&D investor call
Presentation (Webcast)
Presentation (pdf)
07 June: Approval of Wegovy™ in the US
Presentation
(Webcast)
Presentation (pdf)
21 May: International Operations call
Presentation
(Webcast)
Presentation (pdf)
16 December: Decision to enter phase 3 development in Alzheimer’s disease and GLP-1 R&D strategy update
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
Investors
Share price
{{priceData.date}} {{priceData.time}}